There is evidence that the hormonal control of hepatic IGF-I production is mediated by GH and insulin. To elucidate the role of these hormones further we administered s.c. or i.p. insulin (at 2\m=.\5and 5\m=.\0
INTRODUCTION
Insulin-dependent diabetes is associated with a reduction in somatic growth (Tattersall 8c Pike, 1973) which is often accompanied by low serum levels of insulin-like growth factor-I (IGF-I) (Amiel et al. 1984) . Insulin therapy has been shown to restore growth in human patients (Rudolf et al. 1981) and other animals (Scott & Baxter, 1986) and to increase serum IGF-I levels towards normal values.
An infusion of purified human IGF-I into diabetic rats has been reported to enhance growth signifi¬ cantly (Scheiwiller et al. 1986 ). IGF-I is a circulât-ing polypeptide with a chemical structure similar to proinsulin (Rinderknecht & Humbel, 1978) , with both mitogenic (Sara & Hall, 1990) and metabolic (Rossetti et al. 1991) actions. These may be mediated by IGF-I acting in an autocrine, paracrine and endocrine manner (Holly & Wass, 1989) . IGF-I can mimic the growth-promoting effect of growth hor¬ mone (GH), and is thought to mediate many of the actions of GH on target tissues (Froesch et al. 1985) .
Whilst IGF-I and IGF-I mRNA have been found in many tissues (D'Ercole et al. 1984; Murphy et al. 1987b ; Sara & Hall, 1990) , the (Schwander et al. 1983 ). The primary regulator of IGF-I levels is GH (Mathews et al. 1986 ) but there is some evidence to suggest that nutritional state (Bornfeldt et al. 1989; Goldstein et al. 1991 ; VandeHaar et al. 1991) and insulin (Böni-Schnetzler et al. 1991 ) may exert independent influences. The role of the direct portal vascular link between the pancreas and the liver with respect to mobilization of hepatic glycogen stores by glucagon is established (Baron et al. 1987) , whilst the importance of this route for the actions of insulin is controversial and poorly understood (Starzl et al. 1962; Botz et al. 1976) . With respect to the effect of insulin on hepatic IGF-I synthesis, Griffen et al. (1987) (Feinberg & Vogelstein, 1984) . After hybridization, membranes were washed ini¬ tially at room temperature with 2 x SSC, 0-1% (w/v) SDS and then with 0-1 x SSC, 01% (w/v) SDS for 1 h at 55°C. This probe detected a number of transcript sizes, the smallest of which was the most abundant, as found by others using this cDNA probe (Murphy et al. 1987a,b; Murphy, 1988) , and was used for quantitation. Membranes were also hybrid¬ ized with human hypoxanthine phosphoribosyltransferase cDNA (Jolly et al. 1983) , as a control for differences in the amount of RNA loaded on the gel. Autoradiographs were analysed by laser densitometry (UltroScan XL laser densitometer using 2400 GelScan XL; LKB, Turku, Finland). 298-0±4-0cf l-76±0-05f 13-2±0-3cd "P<004, bi"<0-02, CP<001 compared with control rats.
P<0-03, rP<0-02, P<0-01 compared with diabetic rats (analysis of variance).
Statistical analyses Data were analysed using the Number Cruncher Statistical System (Hintze, 1987) Fig. 1 . Laser densitometric analyses of multiple autoradiographs indicated differences (F= 13-77, P<0001) between treatment groups. For comparison, results for the amount of IGF-I mRNA are expressed as percentages of that in con¬ trol animals (Fig. 2) . Hepatic IGF-I mRNA was less in the diabetic animals (optical density (OD) (Fig. 2) . 
DISCUSSION
The primary finding in these studies was that the reduced levels of hepatic IGF-I mRNA, characteris¬ tic of diabetes, were more effectively restored towards normal values by i.p. than by s.c. insulin at 50IU/24h. Insulin is almost entirely absorbed from the peritoneum by the hepatic portal circula¬ tion (Selam et al. 1990) to findings in anaesthetized pancreatectomized dogs (Botz et al. 1976 ). This is in contrast to the results of Griffen et al. (1987) , who reported that, at low dose, insulin delivered via the hepatic portal vein in diabetic rats was more effective at lowering blood glucose than a similar dose given via the jugular vein. However, at high dose no such differences were found. Administration of GH alone did not change blood glucose levels in the diabetic rats. Additional administration of low dose insulin reduced the hyperglycaemia to levels which were higher than, but not significantly different from, those in rats receiving low dose insulin alone, suggesting that these supraphysiological doses of GH may have induced insulin resistance. This is in accord with results from diabetic rats bearing a GH tumour, which required considerably higher insulin doses to reduce glycaemia to an equivalent extent (Fagin et al. 1989) .
Diabetes resulted in a slight loss in body weight over the time of the experiment, as found in other studies (Scheiwiller et al. 1986; Bornfeldt et al. 1989) , but this was ameliorated by treatment with insulin or GH. However, GH alone was less effective than GH plus insulin at increasing body weight or muscle weight above values in diabetic rats, and con¬ firms the findings that GH and insulin are required for effective growth and weight gain in hypophysectomized (Murphy et al. 1987a ) and diabetic (Fagin et al. 1989) rats. The approximately fivefold reduction in hepatic IGF-I mRNA levels in diabetic rats compared with controls reported here is similar to the findings of other workers (Murphy, 1988; Böni-Schnetzler et al. 1989; Bornfeldt et al. 1989; Fagin et al. 1989 ). Despite similar blood glucose values, the IGF-I mRNA level in GH-treated diabetic rats was higher than that in untreated diabetic rats. Thus, expression of hepatic IGF-I mRNA may be independent of blood glucose concentration in these animals. GH is required for insulin to induce hepatic IGF-I mRNA levels; in hypophysectomized rats, GH partially restored hepatic IGF-I mRNA levels (Roberts et al. 1986 ), whilst insulin had no consistent effects (Salamon et al. 1989 ). However, in the present study, we have shown that GH will increase levels of hepatic IGF-I mRNA in the presence of the severely reduced endogenous insulin levels in rats made diabetic with streptozotocin. It is worth noting that in streptozotocin-induced diabetic rats the levels of circulating GH are reduced, in contrast to diabetic humans in whom levels are elevated. Diabetic rats given GH and diabetic rats given GH plus insulin showed 3-6-and 4-7-fold increases in hepatic IGF-I mRNA respectively; this compares with the respec¬ tive 38-and 6-7-fold increases found in isolated hepatocytes (Böni-Schnetzler et al. 1989 (Wurzburger et al. 1991) . The contribution of insulin to the regulation of body growth (Hill & Milner, 1985) may thus be potentiated by the direct link between the pancreatic ß cell and the liver.
